Company announces Chief Financial Officer transition LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2020. For the third quarter of 2020, worldwide sales from continuing operations were $240.1 million, a decrease of 10.6 percent on a reported […]
Other News
First Patients Treated with the World’s Smallest Heart Pump, the 9Fr Impella ECP
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart pump in the world. It measures 9 French (Fr) (3 millimeters) in diameter upon insertion and removal from the body. While in the heart, […]
BioSig Issues October 2020 Shareholder Update Letter
Westport, CT, Oct. 28, 2020 (GLOBE NEWSWIRE) — Company’s PURE EP™ System’s data-driven commercialization is gaining acceptance through new evaluative installations at medical centers of excellence The strongest cash balance in its history positions the Company well to execute on its strategic goals. BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or […]
Pediatric and Congenital Heart Services Expands to Meet Growing Need
Highly specialized pediatric cardiologists join Medical City Children’s Hospital Heart Center DALLAS, Oct. 27, 2020 /PRNewswire/ — To meet the growing need for expert congenital heart care in North Texas, Vivian Dimas, MD, Poonam P. Thankavel, MD, and Ilana J. Zeltser, MD, three highly distinguished pediatric cardiologists, have joined Medical City Children’s Cardiology Specialists. Medical City Children’s […]
Maxim Integrated’s Health Sensor Platform 3.0 Reduces Development Time of Healthcare Wearables by At Least Six Months
MAXREFDES104# is a wrist form factor reference design ready to collect blood oxygen, ECG, heart rate, body temperature and activity data SAN JOSE, Calif., Oct. 28, 2020 /PRNewswire/ — Save at least six months of development time using the Health Sensor Platform 3.0 (HSP 3.0) from Maxim Integrated Products, Inc. (NASDAQ: MXIM). Also […]
Northwestern Medicine Partners with Caption Health to Introduce New Artificially Intelligent Ultrasound Systems into Clinical Practice
Northwestern Memorial Hospital First in Country to Adopt Caption AI in Multiple Clinical Settings CHICAGO, Oct. 28, 2020 /PRNewswire/ — Northwestern Memorial Hospital is the first hospital in the United States to purchase Caption Health’s artificial intelligence (AI) technology for ultrasound, Caption AI. The FDA cleared, AI-guided ultrasound system enables healthcare providers to acquire and […]
Neovasc Announces FDA Advisory Panel Result on Neovasc Reducer™ Medical Device for the Treatment of Refractory Angina
VANCOUVER and MINNEAPOLIS, Oct. 28, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the United States Food and Drug Administration’s (FDA’s) Circulatory System Devices Advisory Panel voted 14 to 4 “in favor” that the Neovasc Reducer™ is safe when used as intended, and voted 1 to […]
Bayer Signs Letter of Intent to Build New Distribution Center in Saxonburg, PA
New 220,000 square-foot Distribution Center to support ongoing growth of business PITTSBURGH–(BUSINESS WIRE)–Bayer announced its plans to build a new 220,000 sq. ft. Distribution Center to support the ongoing growth of Bayer’s Radiology global business that supplies medical device products world-wide. A 10-year lease with optional extensions is being negotiated. […]
CHF Solutions Announces Deployment of Aquadex Systems to Hospitals in the Southeast to Treat COVID-19 Patients
EDEN PRAIRIE, Minn., Oct. 27, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped Aquadex™ product to medical facilities in Tennessee and South Carolina to treat critically ill patients suffering […]
VALBIOTIS Presents the First Market Data on Untreated LDL-hypercholesterolemia For TOTUM-070, And Announces the Initiation of The Phase II Clinical Study HEART
TOTUM-070 is being developed particularly for individuals with untreated hypercholesterolemia, with LDL-cholesterol levels up to 190 mg/dL associated with moderate overall cardiovascular risk. It responds to an unmet medical need for this population; TOTUM-070 has high potential in the market for non-drug LDL-cholesterol products, which is estimated at 1.2 billion […]



